Position in HLN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,799
-$204 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#551
of 639 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Provenance Wealth Advisors, LLC holds $8,905 across 5 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (31.4% of the industry book) .
All Filings in HLN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,799 | 300 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $3,003 | 300 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,033 | 300 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,691 | 300 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,111 | 300 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $4,290 | 417 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $3,978 | 417 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $4,411 | 417 | Shares | Sole | 2025-08-15 | |
| 2024-06-30 | $3,444 | 417 | Shares | Sole | 2025-08-15 | |
| 2024-03-31 | $7,191 | 847 | Shares | Sole | 2025-08-15 | |
| 2023-12-31 | $6,970 | 847 | Shares | Sole | 2025-08-15 | |
| 2023-09-30 | $2,499 | 300 | Shares | Sole | 2025-08-15 | |
| No filing history on record for this holder in this stock. | ||||||